Lobbying Filing Details
Total Spending
$60,000
Activities
1
Lobbyists
6
Gov't Entities
2
Filing Information
- Filing UUID:
c5305ed6-53d3-4bbf-bdaa-3f5dbfcbb04e- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2026 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 20, 2026 at 7:29 PM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Beth Anne Cole
Registrant
TODD STRATEGY GROUP
​Government Affairs Consulting Firm.
Washington, District of ColumbiaClient
ALNYLAM PHARMACEUTICALS, INC.
Biopharmaceutical company
Massachusetts, United States of AmericaLobbying Activities (1)
Activity 1
Medicare/MedicaidMedicare and Medicaid Issues. H.R.1672: Maintaining Investments in New Innovation Act. H.R.946: ORPHAN Cures Act.
Lobbyists (6)
- DANIEL M TODD
- PAUL EDATTEL
- TED LEHMAN
- KATHERINE FLEMING COTTON
- ERIC BERGREN
- MR. NICOLAS MAGALLANES
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES